1. Home
  2. AUPH vs SGML Comparison

AUPH vs SGML Comparison

Compare AUPH & SGML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • SGML
  • Stock Information
  • Founded
  • AUPH 1993
  • SGML 2011
  • Country
  • AUPH Canada
  • SGML Brazil
  • Employees
  • AUPH N/A
  • SGML N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • SGML Industrial Machinery/Components
  • Sector
  • AUPH Health Care
  • SGML Industrials
  • Exchange
  • AUPH Nasdaq
  • SGML Nasdaq
  • Market Cap
  • AUPH 1.1B
  • SGML 1.2B
  • IPO Year
  • AUPH 1999
  • SGML N/A
  • Fundamental
  • Price
  • AUPH $7.93
  • SGML $11.63
  • Analyst Decision
  • AUPH Strong Buy
  • SGML Strong Buy
  • Analyst Count
  • AUPH 3
  • SGML 2
  • Target Price
  • AUPH $10.33
  • SGML $18.00
  • AVG Volume (30 Days)
  • AUPH 1.0M
  • SGML 456.1K
  • Earning Date
  • AUPH 02-27-2025
  • SGML 03-31-2025
  • Dividend Yield
  • AUPH N/A
  • SGML N/A
  • EPS Growth
  • AUPH N/A
  • SGML N/A
  • EPS
  • AUPH N/A
  • SGML N/A
  • Revenue
  • AUPH $220,361,000.00
  • SGML $142,748,436.00
  • Revenue This Year
  • AUPH $36.97
  • SGML $32.37
  • Revenue Next Year
  • AUPH $16.43
  • SGML $54.11
  • P/E Ratio
  • AUPH N/A
  • SGML N/A
  • Revenue Growth
  • AUPH 38.72
  • SGML 48.43
  • 52 Week Low
  • AUPH $4.71
  • SGML $8.47
  • 52 Week High
  • AUPH $10.67
  • SGML $19.20
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 47.47
  • SGML 54.67
  • Support Level
  • AUPH $7.50
  • SGML $10.93
  • Resistance Level
  • AUPH $8.12
  • SGML $11.39
  • Average True Range (ATR)
  • AUPH 0.27
  • SGML 0.54
  • MACD
  • AUPH 0.02
  • SGML 0.11
  • Stochastic Oscillator
  • AUPH 53.49
  • SGML 86.67

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

About SGML Sigma Lithium Corporation

Sigma Lithium Corp is dedicated to powering the next generation of electric vehicle batteries with environmentally sustainable and high-purity lithium. The company is in construction at its wholly owned Grota do Cirilo Project in Brazil, one of the highest-grade hard rock lithium spodumene deposits in the Americas.

Share on Social Networks: